Skip to Main Content

Author Details

Natasja G Lieuwes
Maastricht University
2003
46
23
PMIDPaper TitleJournal TitlePublished Year
37211565Treating colorectal peritoneal metastases with an injectable cytostatic loaded supramolecular hydrogel in a rodent animal model.Clin Exp Metastasis2023
37385265A deep-learning assisted bioluminescence tomography method to enable radiation targeting in rat glioblastoma.Phys Med Biol2023
35111981Inter-observer variability of organ contouring for preclinical studies with cone beam Computed Tomography imaging.Phys Imaging Radiat Oncol2022
35714611A deep learning and Monte Carlo based framework for bioluminescence imaging center of mass-guided glioblastoma targeting.Phys Med Biol2022
35413180'On the Spot' Digital Pathology of Breast Cancer Based on Single-Cell Mass Spectrometry Imaging.Anal Chem2022
35061600Automatic contouring of normal tissues with deep learning for preclinical radiation studies.Phys Med Biol2022
34625504Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506.Mol Cancer Ther2021
33762202Pharmacological inhibition of 17β-hydroxysteroid dehydrogenase impairs human endometrial cancer growth in an orthotopic xenograft mouse model.Cancer Lett2021
33688020Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19-IL2 cures poorly immunogenic tumors when combined with radiotherapy.J Immunother Cancer2021
32509579Mitochondrial Dysfunction Inhibits Hypoxia-Induced HIF-1α Stabilization and Expression of Its Downstream Targets.Front Oncol2020
32929365<i>E. coli</i> nitroreductase NfsA is a reporter gene for non-invasive PET imaging in cancer gene therapy applications.Theranostics2020
32549357Use of a Luciferase-Expressing Orthotopic Rat Brain Tumor Model to Optimize a Targeted Irradiation Strategy for Efficacy Testing with Temozolomide.Cancers (Basel)2020
30465693An orthotopic non-small cell lung cancer model for image-guided small animal radiotherapy platforms.Br J Radiol2019
31431383Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity.Radiother Oncol2019
29632732The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses.Oncoimmunology2018
30154339Development of an Image-Guided Orthotopic Xenograft Mouse Model of Endometrial Cancer with Controllable Estrogen Exposure.Int J Mol Sci2018
28774597Nintedanib reduces radiation-induced microscopic lung fibrosis but this cannot be monitored by CT imaging: A preclinical study with a high precision image-guided irradiator.Radiother Oncol2017
28493648Detection of Localized Hepatocellular Amino Acid Kinetics by using Mass Spectrometry Imaging of Stable Isotopes.Angew Chem Int Ed Engl2017
28502472A novel concept for tumour targeting with radiation: Inverse dose-painting or targeting the "Low Drug Uptake Volume".Radiother Oncol2017
26923459In vivo optical imaging of MMP2 immuno protein antibody: tumor uptake is associated with MMP2 activity.Sci Rep2016
27322137Synthesis and in Vivo Biological Evaluation of (68)Ga-Labeled Carbonic Anhydrase IX Targeting Small Molecules for Positron Emission Tomography.J Med Chem2016
27513947The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy.PLoS One2016
25552483Radiotherapy combined with the immunocytokine L19-IL2 provides long-lasting antitumor effects.Clin Cancer Res2015
26276892Preclinical Assessment of Efficacy of Radiation Dose Painting Based on Intratumoral FDG-PET Uptake.Clin Cancer Res2015
26324018New ways to image and target tumour hypoxia and its molecular responses.Radiother Oncol2015
26163091Is there a causal relationship between genetic changes and radiomics-based image features? An in vivo preclinical experiment with doxycycline inducible GADD34 tumor cells.Radiother Oncol2015
26138057Combination of radiotherapy with the immunocytokine L19-IL2: Additive effect in a NK cell dependent tumour model.Radiother Oncol2015
25708744[(18)F]VM4-037 MicroPET Imaging and Biodistribution of Two In Vivo CAIX-Expressing Tumor Models.Mol Imaging Biol2015
25805800TH-302 in Combination with Radiotherapy Enhances the Therapeutic Outcome and Is Associated with Pretreatment [18F]HX4 Hypoxia PET Imaging.Clin Cancer Res2015
25491505A comparative study of the hypoxia PET tracers [¹⁸F]HX4, [¹⁸F]FAZA, and [¹⁸F]FMISO in a preclinical tumor model.Int J Radiat Oncol Biol Phys2015
24378650Development and biological evaluation of ⁹⁹mTc-sulfonamide derivatives for in vivo visualization of CA IX as surrogate tumor hypoxia markers.Eur J Med Chem2014
25743108Complementary use of bioluminescence imaging and contrast-enhanced micro-computed tomography in an orthotopic brain tumor model.Mol Imaging2014
25200196A longitudinal evaluation of partial lung irradiation in mice by using a dedicated image-guided small animal irradiator.Int J Radiat Oncol Biol Phys2014
23849171Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs.Radiother Oncol2013
22722312Independent and functional validation of a multi-tumour-type proliferation signature.Br J Cancer2012
21676479Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation.Radiother Oncol2011
21873245Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging.Proc Natl Acad Sci U S A2011
21665307Deregulation of cap-dependent mRNA translation increases tumour radiosensitivity through reduction of the hypoxic fraction.Radiother Oncol2011
21704399miR-210 as a marker of chronic hypoxia, but not a therapeutic target in prostate cancer.Radiother Oncol2011
20610160Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia.Nucl Med Biol2010
19251093Inhibition of 4E-BP1 sensitizes U87 glioblastoma xenograft tumors to irradiation by decreasing hypoxia tolerance.Int J Radiat Oncol Biol Phys2009
19616332Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model.Radiother Oncol2009
17512071Expression of EGFR variant vIII promotes both radiation resistance and hypoxia tolerance.Radiother Oncol2007
17531336Development and evaluation of a cetuximab-based imaging probe to target EGFR and EGFRvIII.Radiother Oncol2007
14609542Cerebrospinal fluid monoamine and metabolite concentrations and aggression in rats.Horm Behav2003
12931952Activation of serotonergic neurotransmission during the performance of aggressive behavior in rats.Behav Neurosci2003
  • 1 - 46 of 46

Recommended Authors

Milan Grkovski
Memorial Sloan Kettering Cancer Center
Career Start Year 2012
Number of shared co-authors 1
Bianca A W Hoeben
Radboud University Medical Center
Career Start Year 2010
Number of shared co-authors 9
Pedram Heidari
Massachusetts General Hospital
Career Start Year 2008
Number of shared co-authors 0
Joost J C Verhoeff
University Medical Center Utrecht
Career Start Year 2005
Number of shared co-authors 4
Pardeep Kumar
National Institute of Mental Health & Neurosciences (NIMHANS)
Career Start Year 2005
Number of shared co-authors 1
Stephane Ferretti
Novartis Institutes for BioMedical Research
Career Start Year 2003
Number of shared co-authors 0
Philip Wong
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 2
Trevor D McKee
University Health Network
Career Start Year 2001
Number of shared co-authors 3
Christopher D Willey
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Career Start Year 1999
Number of shared co-authors 1
Francesca M Buffa
University of Oxford
Career Start Year 1998
Number of shared co-authors 11
Christopher Calabrese
St. Jude Children's Research Hospital
Career Start Year 1997
Number of shared co-authors 0
Gang Niu
The First Affiliated Hospital of Xi'an Jiaotong University
Career Start Year 1997
Number of shared co-authors 0
Christopher Ryan Miller
University of Illinois at Urbana-Champaign
Career Start Year 1996
Number of shared co-authors 0
Puneeth Iyengar
UT Southwestern Medical Center, Center for Human Nutrition
Career Start Year 1996
Number of shared co-authors 1
Neeta Pandit-Taskar
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 0
Kevin Camphausen
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Juri G Gelovani
Karmanos Cancer Institute (KCI), Wayne State University
Career Start Year 1990
Number of shared co-authors 0
Roger Stupp
Northwestern University
Career Start Year 1990
Number of shared co-authors 1
Emile E Voest
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 3
Johannes H A M Kaanders
Radboud University Medical Center
Career Start Year 1987
Number of shared co-authors 14
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 1
Michael A Vogelbaum
Moffit Cancer Center
Career Start Year 1986
Number of shared co-authors 1
John L Humm
Memorial Sloan Kettering Cancer Center
Career Start Year 1986
Number of shared co-authors 6
James P Basilion
Case Western Reserve University
Career Start Year 1985
Number of shared co-authors 0
Helen J Ross
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 2
John P Kirkpatrick
Duke University Medical Center
Career Start Year 1978
Number of shared co-authors 1
Rakesh K Jain
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1978
Number of shared co-authors 1
Peter S Conti
Keck School of Medicine of USC
Career Start Year 1971
Number of shared co-authors 0
Richard P Hill
Princess Margaret Cancer Centre
Career Start Year 1968
Number of shared co-authors 4

Collaborators

Ludwig Dubois
Maastricht University
Co-authored papers 43
Philippe Lambin
Maastricht University
Co-authored papers 29
Bradly G Wouters
Princess Margaret Cancer Centre, University Health Network and, University of Toronto
Co-authored papers 6
Marc Vooijs
Maastricht University Medical Centre+
Co-authored papers 4
Wouter van Elmpt
Maastricht University Medical Center+
Co-authored papers 4
Jeroen J J P van den Beucken
Radboud University Medical Center
Co-authored papers 2
Marianne Koritzinsky
Princess Margaret Cancer Centre University Health Network
Co-authored papers 2
Dirk De Ruysscher
Maastro Clinic
Co-authored papers 2
Esther G C Troost
German Cancer Research Center (DKFZ)
Co-authored papers 2
Albert J van der Kogel
University of Wisconsin School of Medicine and Public Health
Co-authored papers 2
Johan Bussink
Radboud University, Nijmegen Medical Centre
Co-authored papers 2
Marike W van Gisbergen
Maastricht University
Co-authored papers 2
Georgi Nalbantov
Department of Radiation Oncology (MAASTRO Clinic)
Co-authored papers 1
Hanneke W M van Laarhoven
Cancer Center Amsterdam
Co-authored papers 1
Maud H W Starmans
Ontario Institute for Cancer Research
Co-authored papers 1
Micha??l G Magagnin
GROW Research Institute, Maastricht University
Co-authored papers 1
Syed Haider
Institute of Cancer Research
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
An M Voets
Maastricht University Medical Centre
Co-authored papers 1
Adrian L Harris
University of Oxford
Co-authored papers 1
Francis Nguyen
Ontario Institute for Cancer Research
Co-authored papers 1
Ruud G P M van Stiphout
University of Oxford
Co-authored papers 1
Fred C G J Sweep
Radboud University Medical Centre
Co-authored papers 1
Roland F Hoffmann
University of Groningen, University Medical Center Groningen
Co-authored papers 1
Paul N Span
Radboud University Medical Center
Co-authored papers 1
Ralph T H Leijenaar
Maastricht University Medical Center (MUMC+)
Co-authored papers 1
Hugo J W L Aerts
Harvard Medical School
Co-authored papers 1
Release 1.2